| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.42B | 6.55B | 7.09B | 6.63B | 5.21B | 3.92B |
| Gross Profit | 2.99B | 2.87B | 2.45B | 2.62B | 2.25B | 2.34B |
| EBITDA | 3.54B | 3.99B | 3.28B | 3.40B | 3.13B | 3.28B |
| Net Income | 1.85B | 1.83B | 1.67B | 1.66B | 1.45B | 1.51B |
Balance Sheet | ||||||
| Total Assets | 31.56B | 30.46B | 24.41B | 21.74B | 21.30B | 19.92B |
| Cash, Cash Equivalents and Short-Term Investments | 3.56B | 5.25B | 4.78B | 3.95B | 4.73B | 4.32B |
| Total Debt | 13.83B | 14.58B | 7.88B | 5.96B | 6.70B | 5.17B |
| Total Liabilities | 16.76B | 16.22B | 9.55B | 7.62B | 7.80B | 7.98B |
| Stockholders Equity | 13.36B | 12.83B | 13.34B | 12.66B | 11.92B | 11.39B |
Cash Flow | ||||||
| Free Cash Flow | 939.86M | 1.34B | 280.46M | 536.98M | 621.72M | 1.67B |
| Operating Cash Flow | 2.35B | 3.54B | 2.63B | 2.65B | 1.94B | 2.10B |
| Investing Cash Flow | -4.17B | -3.05B | -1.96B | -3.12B | -2.48B | 200.18M |
| Financing Cash Flow | 2.54B | 831.93M | 484.45M | -1.48B | 83.27M | -911.04M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$67.15B | 8.26 | 11.50% | 5.43% | -16.77% | -1.46% | |
69 Neutral | HK$31.07B | 10.40 | 14.74% | 5.08% | -5.31% | 10.69% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | HK$6.76B | 10.49 | 5.90% | 5.26% | 12.06% | -19.10% | |
61 Neutral | HK$21.07B | 8.52 | 7.54% | 5.82% | -16.28% | -1.83% | |
60 Neutral | HK$3.54B | 4.38 | 6.26% | 6.05% | -66.15% | -21.01% | |
55 Neutral | HK$23.27B | 8.30 | 4.88% | 3.72% | 4.71% | -4.62% |